Managing allergic rhinitis and asthma: Analyzing the role of Montelukast-Levocetirizine combination Dr. Kamal Kant Kohli15 Dec 2021 11:57 AM ISTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Montelukast - Preferred Choice in Long Term Management of Respiratory Allergies Dr. Kamal Kant Kohli25 Nov 2021 11:20 AM ISTRespiratory Allergies in India - Unique Challenges & Need for Early Interventions An estimated 300 million people worldwide have asthma, with...
Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? dr. Abhimanyu Uppal9 Nov 2021 12:31 PM ISTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
Physician's choice of antihistaminic-leukotriene antagonist combination: An evidence-based comparison of montelukast-fexofenadine versus montelukast- levocetirizine dr. Abhimanyu Uppal8 Sept 2021 12:12 PM ISTNew Delhi: The pandemic restrictions are unlocking amid the looming fear of a 3rd COVID wave at this year's end. Physicians need to be aware and...
New updates in COVID-19 research: Emerging therapeutic role of Fexofenadine and Montelukast. dr. Abhimanyu Uppal10 July 2021 11:17 AM ISTThe dawn of the year 2020 witnessed the surge of one of the biggest pandemics known to mankind. COVID-19 spread through continents affecting millions...
Akums Drugs Montelukast Sodium, Bilastine FDC gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Jun 2021 11:15 AM ISTNew Delhi: The Subject Expert Committee functional under the Central Drugs Standard Control Organization (CDSCO) has given its clearance to Akums...
Oral Montelukast Reduces Risk of Diabetic Retinopathy: ARVO 2021 Dr Kartikeya Kohli9 Jun 2021 9:00 AM ISTChronic inflammation and oxidative stress are critical components in the pathogenic cascade of early diabetic retinopathy, characterized by neuronal...
Montelukast not linked to increased risk of ADHD in kids with Asthma: Study Dr. Nandita Mohan7 Dec 2020 8:15 AM ISTAccording to a nationwide population-based cohort study, researchers have revealed that asthma children treated with montelukast were not at an...
Montelukast must have boxed warning for neuropsychiatric events risk insists FDA Dr. Kamal Kant Kohli5 March 2020 7:33 AM ISTThe U.S. Food and Drug Administration has issued instructions to manufacturers of montelukas to strengthen an existing warning about the risk of...
